These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 33125119)
1. Diverse molecular functions of aspartate β‑hydroxylase in cancer (Review). Zheng W; Wang X; Hu J; Bai B; Zhu H Oncol Rep; 2020 Dec; 44(6):2364-2372. PubMed ID: 33125119 [TBL] [Abstract][Full Text] [Related]
2. Aspartate β-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1α/GSK3β crosstalk. Barboro P; Benelli R; Tosetti F; Costa D; Capaia M; Astigiano S; Venè R; Poggi A; Ferrari N Carcinogenesis; 2020 Sep; 41(9):1246-1252. PubMed ID: 32525968 [TBL] [Abstract][Full Text] [Related]
3. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763 [TBL] [Abstract][Full Text] [Related]
4. Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression. Huang CK; Iwagami Y; Aihara A; Chung W; de la Monte S; Thomas JM; Olsen M; Carlson R; Yu T; Dong X; Wands J PLoS One; 2016; 11(3):e0150336. PubMed ID: 26954680 [TBL] [Abstract][Full Text] [Related]
5. Aspartate β-hydroxylase as a target for cancer therapy. Kanwal M; Smahel M; Olsen M; Smahelova J; Tachezy R J Exp Clin Cancer Res; 2020 Aug; 39(1):163. PubMed ID: 32811566 [TBL] [Abstract][Full Text] [Related]
6. Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis. Nagaoka K; Ogawa K; Ji C; Cao KY; Bai X; Mulla J; Cheng Z; Wands JR; Huang CK Dig Dis Sci; 2021 Apr; 66(4):1080-1089. PubMed ID: 32445050 [TBL] [Abstract][Full Text] [Related]
7. A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma. Aihara A; Huang CK; Olsen MJ; Lin Q; Chung W; Tang Q; Dong X; Wands JR Hepatology; 2014 Oct; 60(4):1302-13. PubMed ID: 24954865 [TBL] [Abstract][Full Text] [Related]
8. Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma. Shimoda M; Tomimaru Y; Charpentier KP; Safran H; Carlson RI; Wands J J Hepatol; 2012 May; 56(5):1129-1135. PubMed ID: 22245894 [TBL] [Abstract][Full Text] [Related]
9. Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma. Nagaoka K; Bai X; Ogawa K; Dong X; Zhang S; Zhou Y; Carlson RI; Jiang ZG; Fuller S; Lebowitz MS; Ghanbari H; Wands JR Cancer Lett; 2019 May; 449():87-98. PubMed ID: 30768955 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the Relationship Between the Expression of Aspartate β-Hydroxylase and the Pathological Characteristics of Breast Cancer. Zhang Y; Gao Y; Li Y; Zhang X; Xie H Med Sci Monit; 2020 Dec; 26():e926752. PubMed ID: 33380715 [TBL] [Abstract][Full Text] [Related]
11. Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation. Huang CK; Iwagami Y; Zou J; Casulli S; Lu S; Nagaoka K; Ji C; Ogawa K; Cao KY; Gao JS; Carlson RI; Wands JR Cancer Lett; 2018 Aug; 429():1-10. PubMed ID: 29733964 [TBL] [Abstract][Full Text] [Related]
12. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Bai X; Sun B; Hung MC; Liu L; Wands J; Dong X Mol Cancer; 2019 Nov; 18(1):156. PubMed ID: 31694640 [TBL] [Abstract][Full Text] [Related]
13. Kinetic parameters of human aspartate/asparagine-β-hydroxylase suggest that it has a possible function in oxygen sensing. Brewitz L; Tumber A; Schofield CJ J Biol Chem; 2020 Jun; 295(23):7826-7838. PubMed ID: 32107312 [TBL] [Abstract][Full Text] [Related]
14. CircTM7SF3 contributes to oxidized low-density lipoprotein-induced apoptosis, inflammation and oxidative stress through targeting miR-206/ASPH axis in atherosclerosis cell model in vitro. Wang X; Bai M BMC Cardiovasc Disord; 2021 Feb; 21(1):51. PubMed ID: 33526034 [TBL] [Abstract][Full Text] [Related]
15. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma. Tomimaru Y; Mishra S; Safran H; Charpentier KP; Martin W; De Groot AS; Gregory SH; Wands JR Vaccine; 2015 Mar; 33(10):1256-66. PubMed ID: 25629522 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update. Hou G; Xu B; Bi Y; Wu C; Ru B; Sun B; Bai X Bosn J Basic Med Sci; 2018 Nov; 18(4):297-304. PubMed ID: 30179586 [TBL] [Abstract][Full Text] [Related]
17. Aspartate β-Hydroxylase Is Upregulated in Head and Neck Squamous Cell Carcinoma and Regulates Invasiveness in Cancer Cell Models. Mukherjee P; Zhou X; Galli S; Davidson B; Zhang L; Ahn J; Aljuhani R; Benicky J; Ailles L; Pomin VH; Olsen M; Goldman R Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732216 [TBL] [Abstract][Full Text] [Related]